Stay updated on Nivolumab with Bevacizumab in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab with Bevacizumab in Glioblastoma Clinical Trial page.

Latest updates to the Nivolumab with Bevacizumab in Glioblastoma Clinical Trial page
- Check4 days agoChange DetectedThe footer’s displayed site revision changes from v3.7.0 to v3.7.1 while the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision: v3.7.0 added. A large set of core study metadata, including investigators and locations, eligibility criteria, and study record details, was removed.SummaryDifference19%

- Check46 days agoChange DetectedThe page adds an NIH grant/contract note to the study identifiers and updates the page revision from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision: v3.6.5 appears on the page, replacing the previous v3.6.4, signaling a routine site update.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page's revision indicator updates from v3.6.3 to v3.6.4, reflecting a new revision entry in the document history.SummaryDifference0.1%

- Check104 days agoChange DetectedThe page now displays Revision: v3.6.3 in the footer, replacing the previous v3.6.2. This indicates a small update to the page's version metadata.SummaryDifference0.1%

Stay in the know with updates to Nivolumab with Bevacizumab in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab with Bevacizumab in Glioblastoma Clinical Trial page.